560
Participants
Start Date
March 1, 2016
Primary Completion Date
January 17, 2019
Study Completion Date
March 4, 2022
Nivolumab
Temozolomide
Radiotherapy
Local Institution - 0057, Lausanne
Local Institution - 0060, Vienna
Universitair Ziekenhuis Brussel, Brussels
Cliniques Universitaires Saint-Luc, Brussels
Local Institution - 0059, Geneva
Royal North Shore Hospital, St Leonards
Local Institution, Copenhagen
Local Institution - 0002, New South Wales
Uz Leuven, Leuven
Local Institution - 0003, Heidelberg
Local Institution - 0004, Prahran
Local Institution - 0061, Linz
Local Institution, Odense
Local Institution - 0001, Nedlands
Local Institution - 0053, Zurich
Columbia University Medical Center (Cumc), New York
Memorial Sloan Kettering Cancer Center, New York
Local Institution - 0077, Torino
Local Institution - 0024, Marseille
Local Institution, Santiago de Compostela
Local Institution - 0132, Allentown
Local Institution - 0007, Philadelphia
Georgetown University Medical Center, Washington D.C.
Local Institution - 0135, Rozzano (milano)
Local Institution - 0079, Milan
Local Institution - 0054, Hamburg
Johns Hopkins University School Of Medicine, Baltimore
Preston Robert Tisch Brain Tumor Center at Duke University, Durham
Local Institution - 0029, Madrid
Local Institution, Madrid
Levine Cancer Institute, Charlotte
Medical University Of South Carolina, Charleston
Emory University - Winship Cancer Institute, Atlanta
Local Institution - 0106, Toulouse
University Of Miami Sylvester Comprehensive Cancer Center, Miami
Moffitt Cancer Center, Tampa
Centre Eugene Marquis, Rennes
Local Institution - 0126, Padua
Vanderbilt University Medical Center, Nashville
Local Institution - 0090, Chattanooga
Local Institution - 0076, Bologna
Norton Cancer Institute, Louisville
Local Institution - 0095, Columbus
Local Institution - 0010, Cleveland
Local Institution - 0025, Valencia
Local Institution - 0050, Münster
Local Institution - 0006, Detroit
Local Institution - 0096, Petah Tikva
Local Institution - 0139, Cologne
Local Institution - 0078, Siena
Local Institution - 0051, Bonn
Local Institution - 0101, Nancy
Local Institution, Lille
Local Institution - 0049, Frankfurt am Main
The University Of Chicago, Chicago
Washington University School OF Medicine-Siteman Cancer Center, St Louis
Local Institution - 0097, Tel Aviv
University Of Kansas Medical Center, Westwood
Local Institution - 0052, Heidelberg
Local Institution - 0032, Bron
Local Institution - 0056, Tübingen
Local Institution - 0023, Paris
Local Institution - 0038, Paris
University Of Texas Md Anderson Cancer Ctr, Houston
Local Institution - 0073, Freiburg im Breisgau
Local Institution - 0080, Gdansk
Local Institution - 0138, Munich
Local Institution - 0068, Salt Lake City
Local Institution - 0083, Phoenix
Cedars Sinai Medical Center, Los Angeles
Local Institution - 0072, Erlangen
Sharp Memorial Hospital, San Diego
Local Institution - 0055, Regensburg
Sutter Institute For Medical Research, Sacramento
Swedish Neuroscience Institute, Seattle
Local Institution - 0070, Moscow
Local Institution - 0105, Moscow
Local Institution - 0114, Chuo-ku
Local Institution - 0128, Bunkyo-ku
Local Institution - 0112, Tokyo
Local Institution - 0133, Sagamihara-shi
Local Institution - 0125, Chiba
Local Institution - 0111, Tsukuba
Local Institution - 0115, Nagoya
Local Institution, Hirakata-shi
Local Institution - 0116, Kyoto
Local Institution - 0129, Kobe
Local Institution - 0134, Okayama
Local Institution - 0123, Hiroshima
Local Institution - 0119, Kumamoto
Local Institution - 0131, Kagoshima
Local Institution - 0121, Kanazawa
Local Institution - 0110, Yamagata
University of Alabama at Birmingham, Birmingham
Local Institution - 0019, Los Angeles
The Regents of the University of California, San Francisco, San Francisco
Yale Cancer Center, New Haven
Dana-Farber Cancer Institute, Boston
Massachusetts General Hospital, Boston
JFK Medical Center, Edison
Local Institution - 0064, Hackensack
University Of Texas Southwestern Medical Center, Dallas
BC Cancer - Vancouver, Vancouver
Princess Margaret Cancer Centre, Toronto
Montreal Neurological Institute and Hospital, Montreal
Local Institution - 0122, Sapporo
Local Institution - 0117, Kyoto
Local Institution - 0130, Suita-shi
Local Institution - 0113, Hidaka
Local Institution - 0118, Mitaka-shi
NKI AVL, Amsterdam
Universitair Medisch Centrum Groningen, Groningen
Erasmus Mc, Rotterdam
Local Institution - 0063, Utrecht
Local Institution, Oslo
Local Institution - 0081, Warsaw
Local Institution, Badalona-Barcelona
Local Institution, Barcelona
Local Institution - 0028, Barcelona
Local Institution, Lund
Local Institution, Solna
University College Hospital, London
Christie Hospital Nhs Found. Trust, Manchester
Royal Marsden Hospital, Sutton
Beaston West of Scotland Cancer Centre, Glasgow
Lead Sponsor
Collaborators (1)
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY